| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/29/2010 | US20100189758 Coating containing pegylated hyaluronic acid and a pegylated non-hyaluronic acid polymer |
| 07/29/2010 | US20100189695 Irak-1 as regulator of diseases and disorders |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/29/2010 | US20100189682 Biologically active proteins having increased In Vivo and/or In Vitro stability |
| 07/29/2010 | US20100189679 Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes |
| 07/29/2010 | US20100189645 Metal chelators and methods of their use |
| 07/28/2010 | EP2210956A2 Method to inhibit cell growth using oligonucleotides |
| 07/28/2010 | EP2210606A2 Methods Of Using And Compositions Comprising Immunomodulatory Compounds For The Treatment And Management Of Myeloproliferative Diseases |
| 07/28/2010 | EP2209776A1 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorder |
| 07/28/2010 | EP2029546B1 Aryl-substituted heterocycles, and use thereof |
| 07/28/2010 | EP1954677B1 Thiomorpholine compound and process for preparing the same |
| 07/28/2010 | EP1633746B1 New indole derivatives as factor xa inhibitors |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | CN101790528A aminoacyl prodrugs |
| 07/28/2010 | CN101787078A Collagen polypeptide, preparation method and application thereof |
| 07/28/2010 | CN101786992A 2-hydroxymethyl-3,5,6-trimethylpyrazine derivatives, preparation methods and application thereof |
| 07/28/2010 | CN101785856A Stably isoosmotic desmoteplase alpha1 or mutant preparation thereof |
| 07/28/2010 | CN101785810A Traditional Chinese medicine preparation for anaphylactoid purpura treatment |
| 07/28/2010 | CN101785800A Traditional Chinese medicine combination for hepatopathy treatment |
| 07/28/2010 | CN101785782A Long-circulating ligustrazine composite injection and preparation method thereof |
| 07/28/2010 | CN101785780A Preparation of cyanocobalamine and adenosine composition and preparation method thereof |
| 07/28/2010 | CN101785765A Disposable hirudin stasis-eliminating hot compressing patch and applications thereof |
| 07/28/2010 | CN101785761A Compound hemostasis medicine and preparation method thereof |
| 07/28/2010 | CN101785581A Smoking-cessation and health-care cigarette holders and using method thereof |
| 07/28/2010 | CN101229367B Process of preparing human fibrinogen preparation |
| 07/27/2010 | US7763738 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 07/27/2010 | US7763729 Bicyclic heteroaromatic derivatives |
| 07/27/2010 | US7763623 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
| 07/27/2010 | US7763611 Aroylsemicarbazide derivatives against thromboembolic diseases |
| 07/27/2010 | US7763597 Salts |
| 07/27/2010 | CA2444266C Use of bile acid or bile salt fatty acid conjugates |
| 07/27/2010 | CA2437587C Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotic agents |
| 07/27/2010 | CA2435425C A suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge |
| 07/22/2010 | WO2010083320A2 Methods and compositions for the inhibition of thrombus formation |
| 07/22/2010 | WO2010082531A1 Active blood coagulation factor inhibitor |
| 07/22/2010 | WO2010012438A3 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 07/22/2010 | US20100184809 Heterocyclic FXR Binding Compounds |
| 07/22/2010 | US20100184784 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 07/22/2010 | US20100184767 Substituted oxazolidinones and use thereof |
| 07/22/2010 | US20100184763 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 07/22/2010 | US20100184740 Substituted oxazolidinones and their use |
| 07/22/2010 | US20100184729 New Pharmaceutical Compositions for Treatment of Thrombosis |
| 07/22/2010 | US20100184672 Protein c for use in maintaining hemostasis |
| 07/22/2010 | US20100184655 Modified erythropoietin |
| 07/22/2010 | US20100183747 Body fluid expanders comprising n-substituted aminosulfonic acid buffers |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183594 Steroid-sparing methods of treating brain edema |
| 07/22/2010 | US20100183589 Human blood proteins expressed in monocot seeds |
| 07/22/2010 | US20100183582 Hemostatic compositions containing sterile thrombin |
| 07/22/2010 | US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport |
| 07/22/2010 | US20100183570 Non-embryonic stem cells and uses thereof |
| 07/22/2010 | US20100183564 Compounds that expand hematopoietic stem cells |
| 07/21/2010 | EP2208782A2 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 07/21/2010 | EP2208726A1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 07/21/2010 | EP2208498A1 Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency |
| 07/21/2010 | EP2207819A1 Anti-microbial polymers and their compositions |
| 07/21/2010 | EP2207555A1 Novel compounds for the treatment or alleviation of edema, and methods for their use |
| 07/21/2010 | EP2207537A2 Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on -adrenergic and/or -adrenergic receptors of the sympathetic nervous system, related to improved clot strength |
| 07/21/2010 | EP1636216B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 07/21/2010 | EP1372529B1 Apparatus for stenting adapted for use in a bifurcated vessel comprising enhanced protection against embolism, restenosis and thrombus formation |
| 07/21/2010 | EP1124961B9 Thrombopoietic compounds |
| 07/21/2010 | CN1872083B Application of monarda glycoside in preparing medicine for treating or preventing hemorrhagic disease |
| 07/21/2010 | CN1732946B Pharmaceutical composition for preventing and treating poultry ascites |
| 07/21/2010 | CN101784560A Blood coagulation factor inhibitors |
| 07/21/2010 | CN101784530A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 07/21/2010 | CN101781347A Polymorphic substances of decitabine and medical compositions |
| 07/21/2010 | CN101781310A Thiofuran-pyridine [3, 2-c] contained acethydrazide derivative and preparation method and application thereof |
| 07/21/2010 | CN101780267A Platelet aggregation inhibition preparation and preparation method thereof |
| 07/21/2010 | CN101780251A Chinese traditional medicine composition for eliminating blood toxicity and improving blood viscosity and preparation method thereof |
| 07/21/2010 | CN101780229A Traditional Chinese medicine composition for treating gum bleeding and preparation method thereof |
| 07/21/2010 | CN101780227A Traditional Chinese medicine composition for treating acute stroke and preparation method thereof |
| 07/21/2010 | CN101780208A TCM preparation for treating subarachnoid hemorrhage |
| 07/21/2010 | CN101780163A Traditional Chinese medicine for treating thrombocytopenic purpura |
| 07/21/2010 | CN101780153A Traditional Chinese drug composition for pig and preparation method and application thereof |
| 07/21/2010 | CN101780142A Leukogenic medicament containing lithium carbonate |
| 07/21/2010 | CN101780109A Traditional Chinese medicine for treating stomach bleeding |
| 07/21/2010 | CN101780092A Compounds and methods for delivery of prostacyclin analogs |
| 07/21/2010 | CN101780084A Injection composition using levo leucovorin or salt thereof as major ingredients |
| 07/21/2010 | CN101780083A Calcium folinate and phenyl alanine composition and preparation method thereof |
| 07/21/2010 | CN101780072A Composition of sodium ozagrel and polyethylene glycol and preparation method thereof |
| 07/21/2010 | CN101780059A Transdermal preparation containing ligustrazine phosphate and preparation method thereof |
| 07/21/2010 | CN101780050A Injection composition using iron polymaltose as major ingredients |
| 07/21/2010 | CN101138545B Clathrate compound containing ginsenoside Rg2 and method of preparing the same |
| 07/21/2010 | CN101085290B Oral administration traditional Chinese medicine composition for treating diabetes insipidus |
| 07/20/2010 | US7759486 2,4,5-Trisubstituted pyrimidine compounds |
| 07/20/2010 | US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain |
| 07/20/2010 | US7759388 Phenylalanine derivatives |
| 07/20/2010 | US7759380 Substituted pyrrolines as kinase inhibitors |
| 07/20/2010 | US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine |
| 07/20/2010 | US7759082 Electroprocessed fibrin-based matrices and tissues |
| 07/20/2010 | CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 07/20/2010 | CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis |
| 07/20/2010 | CA2423857C Malonamide and malonamic ester derivatives with antithrombotic activity |
| 07/20/2010 | CA2399001C Integrin expression inhibitor |
| 07/15/2010 | WO2010080623A2 Anti-fxi antibodies and methods of use |
| 07/15/2010 | WO2010045306A3 Azine derivatives and methods of use thereof |
| 07/15/2010 | WO2009126786A3 Improved quenching methods for red blood cell pathogen inactivation |
| 07/15/2010 | US20100179184 Article of manufacture for prasugrel |
| 07/15/2010 | US20100179152 Novel use for PDE5 inhibitors |
| 07/15/2010 | US20100179128 Xanthine derivatives as selective hm74a agonists |